Pregnancy and Multiple Sclerosis

Archives of Neurology

Volumn 43, Issue 7, 1986, Pages 719-726

  Birk, Kathy ^a   Rudick, Richard ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL NERVOUS SYSTEM; ETIOLOGY; FEMALE GENITAL SYSTEM; HUMAN; MULTIPLE SCLEROSIS; PERIPHERAL NERVOUS SYSTEM; PREGNANCY; PRIORITY JOURNAL; SHORT SURVEY; SURVEY;

ABNORMALITIES, DRUG-INDUCED; ALPHA-FETOPROTEINS; ANIMAL; COMPARATIVE STUDY; COUNSELING; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, EXPERIMENTAL AUTOIMMUNE; FEMALE; FETUS; GUINEA PIGS; HUMAN; IMMUNE TOLERANCE; INFANT, NEWBORN; MULTIPLE SCLEROSIS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY ZONE PROTEINS; PROSTAGLANDINS; PUERPERAL DISORDERS; RABBITS; RATS; RETROSPECTIVE STUDIES; RISK; SUPPORT, U.S. GOV'T, P.H.S.; SUPPRESSOR FACTORS, IMMUNOLOGIC;

EID: 0022638560     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.1986.00520070075022     Document Type: Article

References (90)

1. Scheinberg L: Multiple Sclerosis: A Guide for Patients and Their Families. New York, Raven Press, 1984.
2. Matthews WB, Acheson ED, Batchelor JR, et al: McAlpine's Multiple Sclerosis. New York, Churchill Livingstone Inc, 1985.
3. Poser S, Poser W: Multiple sclerosis and gestation. Neurology 1983;33:1422-1427.
4. Tillman A: The effect of pregnancy on multiple sclerosis and its management. Res Publ Assoc Res Nerv Ment Dis 1950;28:548-582.
5. Muller R: Studies on disseminated sclerosis. Acta Med Scand Suppl 1949;222:1-214.
6. Shapira K, Poskanzer DC, Newell DJ, et al: Marriage, pregnancy and multiple sclerosis. Brain 1966;89:419-428.
7. Millar JHD, Allison RS, Cheeseman EA, et al: Pregnancy as a factor influencing relapse in disseminated sclerosis. Brain 1959;82:417-426.
8. Poser S, Raun NE, Wilstrom J, et al: Pregnancy, oral contraceptives and multiple sclerosis. Acta Neurol Scand 1979;59:108-130.
9. Ghezzi A, Caputo D: Pregnancy: A factor influencing the course of multiple sclerosis? Eur Neurol 1981;20:517-519.
10. Korn-Lubetzki I, Kahana E, Cooper G, et al: Activity of multiple sclerosis during pregnancy and puerperium. Ann Neurol 1984;16:229-231.
11. Sweeney WJ: Pregnancy and multiple sclerosis. Am J Obstet Gynecol 1955;66:124-130.
12. Sadovnick AD, Baird PA: Reproductive counselling for multiple sclerosis patients. Am J Med Genet 1985;20:349-354.
13. Peckham CH: Multiple sclerosis complicating pregnancy. NY State J Med 1945;45:618-622.
14. Birner IM: Pregnancy and multiple sclerosis: Case report. NY State J Med 1945;45:634-635.
15. Douglass LH, Jorgensen CL: Pregnancy and multiple sclerosis. Am J Obstet Gynecol 1948;55:332-336.
16. Evron S, Brenner T, Abramsky O: Suppressive effect of pregnancy on the development of experimental allergic encephalomyelitis in rabbits. Am J Reprod Immunol 1984;5:109-113.
17. Abramsky O, Lubetzki-Korn I, Evron S, et al: Suppressive effect of pregnancy on MS and EAE. Prog Clin Biol Res 1984;146:399-406.
18. Abramsky O, Soffer D, Brenner T: Prevention and treatment of experimental allergic encephalomyelitis by alpha-fetoprotein, abstracted. Neurology 1980;30:173.
19. Abramsky O, Brenner T, Mizrachi R, et al: Alpha-fetoprotein suppresses experimental allergic encephalomyelitis. J Neuroimmunol 1982;2:1-7.
20. Arnason BG, Richman DP: Effect of oral contraceptives on experimental demyelinating disease. Arch Neurol 1969;21:103-108.
21. Greig ME, Gibbons AJ, Elliott GA: A comparison of the effects of melengestrol acetate and hydrocortisone acetate on experimental allergic encephalomyelitis in rats. J Pharmacol Exp Ther 1970;173:85-93.
22. Ovadia H, Evron S, Brenner T, et al: Natural passive transfer of resistance to experimental allergic encephalomyelitis, abstracted. Neurology 1985;35(suppl 1):299.
23. Gall S: Maternal adjustments in the immune system in normal pregnancy. Clin Obstet Gynecol 1983;26:521-536.
24. Weinberg E: Pregnancy-associated depression of cell-mediated immunity. Rev Infect Dis 1984;6:814-831.
25. Rocklin RE, Kitzmiller JL, Kaye MD: Immunobiology of the maternal-fetal relationship. Annu Rev Med 1979;30:375-404.
26. Adelsberg BR: Immunology of pregnancy. Mt Sinai J Med 1985;52:5-10.
27. Wegman T, Gill T: Immunology of Reproduction. New York, Oxford University Press Inc, 1983, pp 365-380.
28. Stahn R, Fabricius HA, Hartleitner W: Suppression of human T-cell colony formation during pregnancy. Nature 1978;276:831-832.
29. Maroulis GB, Buckley RH, Younger JB: Serum immunoglobulin levels during normal pregnancy. Am J Obstet Gynecol 1971;109:971-976.
30. Sridema V, Pacini F, Yang S, et al: Decreased levels of helper T cells: A possible cause of immunodeficiency in pregnancy. N Engl J Med 1982;307:352-356.
31. Hirahara F, Gorai I, Tanaka K, et al: Cellular immunity in pregnancy: Subpopulations of T lymphocytes bearing Fc receptors for IgG and IgM in pregnant women. Clin Exp Immunol 1980;41:353-357.
32. Fugisaki S, Mori N, Sasaki T, et al: Cell-mediated immunity in human pregnancy. Microbiol Immunol 1979;23:899-907.
33. Hogarth PJ: Immunological Aspects of Mammalian Reproduction. New York, Praeger Publishers, 1982, pp 83-449.
34. Froelich C, Goodwin J, Arthur C, et al: Pregnancy: A temporary fetal graft of suppressor cells in autoimmune disease? Am J Med 1980;63:329-331.
35. Cauchi M: Obstetric and Perinatal Immunology. London, Edward Arnold Publishers, 1981, pp 16-36.
36. Murgita RA, Anderson C, Sherman MS, et al: Effects of human alpha-fetoprotein on human B and T lymphocyte proliferation in vitro. Clin Exp Immunol 1978;33:347-356.
37. Peck A, Murgita R, Wigzell H: Cellular and genetic restrictions in the immunoregulatory activity of alpha-fetoprotein. J Exp Med 1978;147:667-682.
38. Murgita RA, Goidl EA, Kontiainen S, et al: Alpha-fetoprotein induces suppressor T cells in vitro. Nature 1977;267:257-259.
39. Murgita R, Tomas T: Suppression of the immune response by alpha-fetoprotein. J Exp Med 1975;141:269-286.
40. Thomson AW, Hunter CBJ, Cruickshank N, et al: Study of pregnancy associated alpha-2-glycoprotein in relation to populations of human blood leukocytes. Int Arch Allergy Appl Immunol 1979;58:251-259.
41. Stimson WH: Are pregnancy-associated human proteins responsible for the inhibition of lymphocyte transformation by pregnant serum? Clin Exp Immunol 1980;40:157-160.
42. Stimson WH: Studies on immunosuppressive properties of a pregnancy-associated alpha-macroglobulin. Clin Exp Immunol 1976;25:199-206.
43. Schoultz BV: A quantitative study of the pregnancy zone protein in the sera of pregnant and puerperal women. Am J Obstet Gynecol 1974;119:792-797.
44. Sarcione EJ, Delluomo D, Zloty M: Pregnancy associated alpha-2-glycoprotein synthesis by human breast cancer tissue and cultured cell lines. Int J Cancer 1983;31:143-147.
45. Bersinger NA, Klopper A: Serum concentrations of pregnancy-associated plasma protein A in the first trimester of pregnancy. Am J Obstet Gynecol 1984;150:780-782.
46. Bischof P, Duberg S, Herrmann W, et al: Amniotic fluid and plasma concentrations of pregnancy associated plasma protein-A (PAPP A) throughout pregnancy: Comparison with other fetoplacental products. Br J Obstet Gynecol 1982;89:358-363.
47. Bischof P, Geinoz A, Herrmann WL, et al: Pregnancy-associated plasma protein A (PAPP A) specifically inhibits the third component of human complement (C 3). Placenta 1984;5:1-8.
48. Ellingsworth LR, Hayashi LG, Osburn BE, et al: Immunosuppressive activity of rhesus monkey pregnancy serum. Am J Obstet Gynecol 1981;139:932-936.
49. Jacoby DR, Olding LB, Oldstone MBA: Immunologic regulation of fetal-maternal balance. Adv Immunol 1984;35:157-208.
50. Goodwin JS, Messner RP, Peake GT: Prostaglandin suppression of mitogen-stimulated lymphocytes in vitro. J Clin Invest 1978;62:753-760.
51. Johnsen SA, Olding LB, Green K: Conversion of arachidonic acid in human maternal and neonatal mononuclear leukocytes from human newborns on maternal leukocytes: Mediation by prostaglandins. Clin Immunol Immunopathol 1982;23:606-615.
52. Gill TJ, Ripeti CF: Immunologic and genetic factors influencing reproduction. Am J Pathol 1979;95:465-570.
53. Tourtellotte WW, Potvin AR, Fleming JO, et al: Multiple sclerosis: Measurement and validation of central nervous system IgG synthesis rate. Neurology 1980;30:240-244.
54. Vandvik B, Natvig JB, Wiger D: IgGl subclass restriction of oligoclonal IgG from cerebrospinal fluids and brain extracts in patients with multiple sclerosis and subacute encephalitides. Scand J Immunol 1976;5:427-436.
55. Salier J-P, Goust J-M, Pandey JP, et al: Preferential synthesis of the G1m(1) allotype of IgG1 in the central nervous system of multiple sclerosis patients. Science 1981;213:1400-1402.
56. Link H, Muller R: Immunoglobulins in multiple sclerosis and infections of the nervous system. Arch Neurol 1971;25:326-344.
57. Johnson KP, Arrigo SC, Nelson BJ, et al: Agarose electrophoresis of cerebrospinal fluid in multiple sclerosis. Neurology 1977;27:173-191.
58. Traugott U, Reinherz EL, Raine CS: Multiple sclerosis: Distribution of T cells, T cell subsets and Ia-positive macrophages in lesions of different ages. J Neuroimmunol 1983;4:201-221.
59. Haffler DA, Buchsbaum M, Johnson D, et al: Phenotypic and functional analysis of T cells cloned directly from the blood and cerebrospinal fluid of patients with multiple sclerosis. Ann Neurol 1985;18:451-458.
60. Noronha A, Richman DP, Arnason BGW: Multiple sclerosis: Activated cells in cerebrospinal fluid in acute exacerbations. Ann Neurol 1985;18:722-725.
61. Kinnman J, Link H, Moller E, et al: Influence of measles virus antigen on leukocyte migration in multiple sclerosis and controls. Acta Neurol Scand 1978;58:261-271.
62. Dore-Duffy P, Zurier RB: Lymphocyte adherence in multiple sclerosis: Lack of virus specificity. Cell Immunol 1983;77:215-221.
63. Offner H, Konat G: Stimulation of active E rosette forming lymphocytes from multiple sclerosis patients by gangliosides and cerebrosides. J Neurol Sci 1980;46:101-104.
64. Utermohlen V, Zabriskie JB: A suppression of cellular immunity in patients with multiple sclerosis. J Exp Med 1973;138:1591-1596.
65. Santoli D, Hall W, Katrukoff L, et al: Cytotoxic activity and interferon production by lymphocytes from patients with multiple sclerosis. J Immunol 1981;126:1274-1278.
66. Golaz J, Steck A, Moretta L: Activated T lymphocytes in patients with multiple sclerosis. Neurology 1983;33:1371-1373.
67. Hafler DA, Strominger J, Weiner HL: Simultaneous analysis of early and late activation antigens and DNA content of T lymphocytes in multiple sclerosis, abstracted. Neurology 1984;34(suppl):113.
68. Noronha AB, Richman DP, Arnason BGW: Detection of in vivo stimulated cerebrospinal fluid lymphocytes by flow cytometry in patients with multiple sclerosis. N Engl J Med 1980;303:713-717.
69. Birnbaum G, Kotilinek L, Schwartz M: Specific reactivity of spinal fluid lymphocytes in multiple sclerosis patients and controls, abstracted. Neurology 1983;33(suppl 2):131.
70. Reinherz EL, Weiner HL, Hauser SL, et al: Loss of suppressor T cells in active multiple sclerosis: Analysis with monoclonal antibodies. N Engl J Med 1980;303:125-129.
71. Antel JP, Arnason BGW, Medof ME: Suppressor cell function in multiple sclerosis: Correlation with clinical disease activity. Ann Neurol 1979;5:383-342.
72. Prineas JW, Kwon EE, Cho E-S, et al: Continual breakdown and regeneration of myelin in progressive multiple sclerosis plaques. Ann NY Acad Sci 1984;436:11-32.
73. Prineas JW, Graham JS: Multiple sclerosis: Capping of surface immunoglobulin G on macrophages engaged in myelin breakdown. Ann Neurol 1981;10:149-158.
74. Dore-Duffy P, Zurier RB, Donaldson J, et al: Lymphocyte adherence in multiple sclerosis. Neurology 1979;29:232-235.
75. Merrill JE, Myers LW, Ellison GW, et al: Production of and response to IL-2 by lymphocytes from multiple sclerosis patients and controls. Neurology 1984;24(suppl):113.
76. Yam P, Petz LD, Tourtellotte WW, et al: Measurement of complement components in cerebral spinal fluid by radioimmunoassay in patients with multiple sclerosis. Clin Immunol Immunopathol 1980;17:492-505.
77. Rudick RA, Bidlack JM, Knutson DW: Multiple sclerosis: Cerebrospinal fluid immune complexes that bind Clq. Arch Neurol 1985;42:856-858.
78. Burrow GN, Ferris TF: Medical Complications During Pregnancy, ed 2. Philadelphia, WB Saunders Co, 1982.
79. Sadovnick AD: Empiric recurrence risks for use in the genetic counselling of multiple sclerosis patients. Am J Med Genet 1984;17:713-714.
80. Stern L: Drug Use in Pregnancy. Balgowah, Australia, ADIS Health Science Press 1984.
81. Briggs GG, Bodendorger TW, Freeman RK, et al: Drugs in Pregnancy and Lactation. Baltimore, Williams & Wilkins, 1983.
82. Lawrence RA: Breast Feeding: A Guide for the Medical Profession, ed 2. St Louis, CV Mosby Co, 1985.
83. IARC Working Group: Antineoplastic and immunosuppressive agents: Azathioprine. IARC Monogr Eval Carcinog Risk Chem Hum 1981;26:47-48.
84. Symington GR, Mackay IR, Lambert RP: Cancer and teratogenesis: Infrequent occurrence after medical use of immunosuppressive drugs. Aust NZ J Med 1977;7:368-372.
85. Sieber SM, Adamson H: Toxicity of antineoplastic agents in man: Chromosomal aberrations, antifertility effects, congenital malformations, and carcinogenic potential. Adv Cancer Res 1975;22:57-155.
86. Penn I, Makowski EL, Harris P: Parenthood following renal transplantation. Kidney Int 1980;18:221-233.
87. Bamford C, Sibley W, Laguna J: Anesthesia in multiple sclerosis. J Can Sci Neurol 1978;5:41-44.
88. Warren TM, Datta S, Ostheimer GW: Lumbar epidural anesthesia in a patient with multiple sclerosis. Anesth Analg 1982;61:1022-1023.
89. Sillman F, Stanek A, Sedlis A, et al: The relationship between human papillomavirus and lower genital intraepithelial neoplasia in immunosuppressed women. Am J Obstet Gynecol 1984;150:300-308.
90. Schneider V, Kay S, Lee HM: Immunosuppression as a high-risk factor in the development of condyloma acuminatum and squamous neoplasia of the cervix. Acta Cytol 1983;27:220-224.